Net Good IndexSubmit a correction

Benefit Ledger · provisional · Medicine & Health

Novo Nordisk and Anthropic Will Collaborate on Drug Discovery with Claude - CHEManager

Novo Nordisk and Anthropic Will Collaborate on Drug Discovery with Claude  CHEManager

Tier 1 UsefulMethodology 0.2
Submit a correction

Current score

+0.04

1 base · Useful (tier 1 of 5, 1 pts)
× 0.7500 attribution · Critical contribution
× 0.2500 evidence · Technical disclosure or preprint
× 0.4000 realization · Demonstrated
× 0.5000 durability · Medium-term
Event-level product before credit split: 0.04

Ingest update: independent source raised evidence; added a follow-up source. Score remains provisional until review.

What happened

Novo Nordisk and Anthropic Will Collaborate on Drug Discovery with Claude  CHEManager Update (2026-09-16): Novo Nordisk Will Use Anthropic’s Claude for Drug Research - WSJ. Novo Nordisk Will Use Anthropic’s Claude for Drug Research  WSJ

Model attribution

Unspecified AI system
Version unspecified
+0.04

Unspecified

Unspecified system mentioned or implied by a news item. Remap to a named release when identified.

News ingest does not infer a named model from the publisher alone. Attribution stays unspecified until a release is identified.

Attribution 0.7500 · Credit share 100% · Unknown

Claims

  • Novo Nordisk and Anthropic Will Collaborate on Drug Discovery with Claude - CHEManager

    outcome · supported

Sources

primary sources

other sources

Revision history

  • 17 Sep 2026 · 0.00 → 0.02

    Auto-published from news ingest.

  • 17 Sep 2026 · 0.02 → 0.04

    Ingest update: independent source raised evidence; added a follow-up source.

Submit a correction